T1	Participants 73 128	patients treated with anthracycline-based chemotherapy.
T2	Participants 303 340	patients treated with anthracyclines.
T3	Participants 434 474	42 patients treated with anthracyclines.
T4	Participants 554 573	healthy volunteers.
T5	Participants 620 850	21 men and 21 women with a mean age of 55 ± 17 years, who presented a median of 84 months after chemotherapy with a cumulative anthracycline exposure of 282 ± 65 mg/m(2) and a mean left ventricular ejection fraction of 52 ± 12%
T6	Participants 1277 1335	elevated in patients with previous anthracycline treatment
